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Even when looking from outside, cardiology has an impress-
ive tradition in the Czech Republic. Indeed, the Czech Society of
Cardiology was already founded on December 13, 1929, i.e.
decades before Cardiology became a visible medical specialty
in many other countries. As such the Czech Society of Cardiol-
ogy is the second oldest in Europe, just after the German
Society of Cardiology which was founded in 1927. Of note, the
European Society of Cardiology was founded only after the
Second World War, i.e. on September 2, 1950 after represen-
tatives from 14 countries, i.e. Belgium, Denmark, Finland,
France, Greece, Italy, The Netherlands, Norway, Portugal,
Spain, Sweden, Switzerland, United Kingdom and Yugoslavia
had prepared statutes and had elected a provisional Execu-
tive Committee that included C. Laubry (France) as Honorary
President, Gustav Nylin (Sweden) as President, and D.E.
Belford (UK), E. Coehlo (Portugal) and Jean Lenegre (France)
as Vice-Presidents.
The first president of the Czech Society of Cardiology, acting
from 1929–1938 for almost a decade, was Prof. Vaclav
Libensky from Prague. In 1933, he organized the first inter-
national cardiology congress in Prague. As president, he was
followed by 12 eminent Czech cardiologist (Table 1). Most
recently, the society is led by Prof. Petr Widimsky (2011–15),
an internationally recognized interventional cardiologist. Ofnt matter & 2012 The Czech Society of Cardiology.
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.tomluescher.chnote, Pavel Lukl who presided the Czech Society of Cardiology
from 1959–71, was also president of the European Society of
Cardiology from 1964–1968. Today, the Czech Society of Cardiology
has 2271 members, 768 of whom are board certified cardiolo-
gists. Of note, with 3500–4000 participants, the annual congress
of the Czech Society of Cardiology is the largest national medical
congress in the Czech Republic, again reflecting the importance
of this medical specialty in the country.2. The pioneers
Czech physicians contributed early on to modern cardiology.
Indeed, Otto Klein (1881–1968) was as much a pioneer of his
field as Werner Forssmann, Andre´ F. Cournand and Dickinson
W. Richards [1,2]. Although forgotten by the Nobel prize
committee, Otto Klein truly contributed to cardiology, parti-
cularly by his seminal paper published in 1930 on the
determination of cardiac output using the Fick’s principle
[3]. At that time, science was dominated by Germany and
hence it was natural that he published his work in the
Mu¨nchener Medizinische Wochenschrift in German language.
Although he confirmed and importantly expanded Werner
Forssmann’s work, he was ignored by cardiologists on the
other side of the Atlantic and as a consequence also by the
Nobel Prize Committee in 1956. Nevertheless, his seminalPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved..
Table 1 – President of the Czech Society of Cardiology.
Presidents of the Czech
Society of Cardiology
Year
Vaclav Libensky 1929–1938
Klement Weber 1938–1942 and 1951–1955
Stanislav Mentl 1942–1946
Frantisek Herles 1946–1951
Vladimir Haviar 1955–1959
Pavel Lukl 1959–1971 and President of the
ESC 1964–1968
Zdenek Reinis 1971–1981
Vladimir Dufek 1981–1990
Vladimir Stanek 1990–1995
Roman Cerbak 1995–1999
Jaromir Hradec 1999–2004
Michael Aschermann 2004–2008
Vaclav Chaloupka 2008–2011
Petr Widimsky 2011–2015
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Shlomo Stern and Jiri Widimsky through their publications
in Cor Vasa [4], the European Heart Journal and later the Journal
of the American College of Cardiology. In the end, he became a
prime example of the difference between impact and influ-
ence [5]. Although not cited initially due to the language and
impact of the journal his work was published in (the Mu¨nch-
ener Medizinische Wochenschrift currently has an impact factor
of 0.528), he eventually got the recognition he deserved.
In 1938, due to the increasing oppression of the German
Nazi regime that had taken over Czechoslovakia, Otto Klein,
as a Jew, had to resign from his chair and soon thereafter had
to leave his country as many other bright scientists. As a
consequence, research and exchange between scientists and
physicians became increasingly difficult during the war and
remained so for those living behind the iron curtain for many
years thereafter. Czechia was no exception, although it
hosted one of the oldest universities, the Charles University
in Prague.3. Cardiology practice today
Due to the separation of Eastern and Western Europe after
the war, the Czech Society of Cardiology became an official
member of the European Society of Cardiology only in 1968.
Although this facilitated exchange somewhat, it remained
difficult for Czech cardiologists to participate at meetings
abroad and to exchange views and knowhow with their
colleagues in the West or even publish their work in peer-
reviewed journals. After the fall of the Berlin wall and the
iron curtain that separated what truly belonged together, this
changed rapidly and Cardiology developed impressively in
the Czech Republic. Indeed, today there are 11 tertiary cardiac
centers with both departments of cardiology and cardiac
surgery as well as 1 pediatric cardiac center. In addition,
there are another 11 cardiology centers performing percuta-
neous interventions and electrophysiological procedures for
arrhythmias without on-site surgery. Thus, in each of the 13counties of the Czech Republic, i.e. regions with 0.3–1.2
million citizens, at least one cardiology center is available,
thus fully covering the needs of the 10.5 million inhabitants.
Of note and in contrast to many other countries, the Czech
Republic successfully prevented an inflation of cardiology
centers. Indeed, the Czech Ministry of Health, health care
insurance companies (payers), and the Czech Society of
Cardiology jointly rejected applications of several other hos-
pitals for accreditation in interventional cardiology. Since
volume and outcome is closely linked in cardiology and
cardiovascular surgery alike [6–8], this was a wise decision
which so far was only followed by the French government [9].
In contrast to Switzerland, for instance, where one cardiology
center serves only 246,774 inhabitants, one Czech center
serves 477,273 inhabitants and 676,500 in the Netherlands
[10].
This allowed for an increasingly evidence-based practice in
cardiovascular medicine at high technical level. Indeed, the
total number of cardiovascular procedures in the Czech
Republic is impressive with 54,357 coronary angiographies,
22,072 percutaneous coronary interventions (PCI)—which
relates to a ratio of 2.5 to 1 of diagnostic and PCI procedures.
The number of CABG currently is 3930 which relates to a ratio
of 1 to 4.5 compared to PCI. Given the recent evidence that
CABG should more consistently be used particularly in
3-vessel disease [11,12], this possibly reflects a relative over-
use of PCI as is still current clinical practice in many other
countries.
Of note, with 6102 primary procedures for ST-segment eleva-
tion myocardial infarctions (STEMI) in the year 2011, the Czech
Republic follows the most updated ESC Guidelines in the
management of acute coronary syndromes [13,14]. As a con-
sequence, thrombolysis for STEMI was almost abandoned.4. Czech cardiologist at the ESC annual
congress
The Annual Congress of the European Society of Cardiology is a
true success story. Indeed, since the first congress in 1952 the
number of participants as well as abstract submissions and
sessions has increased steadily and reached its maximum
last year with 32,000 attendees in Paris in 2011. In 2011 in
Munich, the annual congress accommodated a total of 27,279
attendees. The largest number of delegates came from
Germany, followed by France, Italy, Japan and the U.S.
(Fig. 1). A total of 214 delegates came from the Czech
Republic, which given its population is an underrepresenta-
tion compared to similar countries such as Switzerland (685),
the Netherlands (660) and Greece (606).
Overall, of those attending the ESC congress in Munich,
21,440 actively participated in the scientific program as either
physicians or scientists, 629 were active press delegates and
5210 were exhibitors. Of note, in 2011 a record number of
abstracts (9614) were submitted and a little less than half of
them (44%; 4203) were accepted for presentation or as
posters. From 2007 to 2012 Czech cardiologists submitted a
total of 553 abstracts, 173 of which were accepted (31%) which
is a bit less than average.
67%
18%
6%
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By geographical region
ESC (Member Countries) ASIA PACIFIC
NORTH AMERICA SOUTH & CENTRAL AMERICA
AFRICA
Country
N °
Delegates Country
N °
Delegates
Germany 2549 Austria 384
France 1126 Argentina 379
Italy 1051 Turkey 363
Japan 975 Sweden 362
USA 971 Belgium 349
Brazil 804 Denmark 342
United Kingdom 781 Romania 322
Spain 768 Portugal 306
Switzerland 685 Australia 262
Netherlands 660 Serbia 247
China 654 Czech Republic 224
Greece 606 Norway 214
India 547 Mexico 209
Russian 
Federation
540 Bulgaria 205
Poland 501 Finland 196
Fig. 1 – Participants at the Annual Congress of the European Society of Cardiology 2012 in Munich from 139 countries.
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ESC congress
Recently, Winnik et al. [15] analyzed over 1000 abstracts
submitted to the Annual Congress of the European Society of
Cardiology and analyzed key success factors of acceptance
and future publication over a 4 years period. Of note, the
congress program committee accepted primarily abstracts on
basic science, those reporting on 100 patients or more and
studies with a prospective and/randomized design. Interest-
ingly, these predictors differed from those anticipating full-
text publication which included academic affiliation and
gender. The single parameter predicting high citation rates
was a randomized study design. Of note, the publication rate
of accepted abstracts was 38%, whereas only 24% of rejected
ones were published. Furthermore, among the abstracts that
were eventually published, those accepted at the ESC Congress
received more citation than rejected ones.6. Czech cardiologists and the European Heart
Journal
It took the European Society of Cardiology 30 years to start their
own journal. Indeed, the European Heart Journal was launched
only in 1980 under the leadership of Desmond Julian followed
by Henry Kulbertus, Kim Fox and Frans van der Werf [16].
Under current leadership with a novel strategy [17], the
European Heart Journal has grown impressively with currently
3800 submissions per year and and impact factor of close to
10.5. As a consequence the acceptance rate of original
research articles has dropped to 11%. However, the current
editor-in-chief introduced the manuscript transfer system
which allows to transfer excellent manuscripts that are either
too specialized and/or just did not make the priority requiredto the ESC journal family which currently contains 11 pro-
ducts (Fig. 2). The manuscript transfer system allows authors
to resubmit their work in a revised version based on the initial
reviews obtained by the European Heart Journal to one of the
subspecialty journal, provided its editors agreed to the trans-
fer. Typically, around 600 manuscripts are transferred in a year
from the main to the subspecialty journals.
Over the last 5 years, i.e. since 2007, Czech cardiologist and
cardiovascular scientists have submitted 107 papers to the
European Heart Journal, mostly Cardiovascular Flashlights, but also
clinical papers, editorials, current opinions and review articles.
Overall the Czech Republic is thus in the middle field of
submitting countries worldwide; indeed, countries of similar size
submit around 60–80 papers per year. Of note, the overall
acceptance rate was 16.3% which is above average of the current
acceptence rate for all manuscript which currently is 11%.
Among the different types of articles, acceptance rate was
slightly higher for Cardiovascular Flashlights (16.7%) than for
original articles (16.1%).
A major criterion for the level of interest a publication attracts,
is its citation index [18]. For a journal this determines the impact
factor and for an author his personal influence within the
scientific process. Within the last 5 years, the best cited original
research article published by a Czech cardiologist was ‘‘Reperfu-
sion therapy for ST-elevation acute myocardial infarction in
Europe. Description of the current situation in 30 countries.‘‘ By
Petr Widimsky and coworkers (cited 63 times) followed by
another article from the same author on ‘‘Clopidogrel pretreat-
ment instable angina: for all patients46 h before elective cor-
onary angiography or only for angiographically selected patients
a few minutes before PCI? A randomized multicenter trial
PRAGUE-8’’ (cited 34 times). Indeed, the entire Prague trial family
is a success story with 29 papers published and overall cited 940
times in the entire scientific literature.
Fig. 2 – The ESC journal family.
c o r e t v a s a 5 5 ( 2 0 1 3 ) e 1 – e 5e47. Perspectives
Thus, looking at it from the outside, the Czech Republic has
developed modern cardiology in an impressive manner at the
clinical level. At the academic level, the country is productive,
but it certainly could—in the tradition of Otto Klein—improve
its contributions in clinical, but particularly in basic
science further both in terms of absolute number of abstracts
and manuscripts submitted as well as acceptance and
citations.
How could this be achieved? Good publishing requires an
innovative idea, proper design and methodology, appropriate
statistics and stringency in writing [19,20]. This requires an
academic environement and an optimal research training. With
the current economization of medicine and austerity pro-
grammes of many governements, this is not always easy to
maintain. Here, the European Society of Cardiology has an impor-
tant role with its educational products, i.e. the main and
subspreciality congresses and the ESC Textbooks [21], the ESC
journal family and their initiatives for the young, i.e. TheCardiologists of Tomorrow and the ESC fellowships. Indeed, aca-
demic exchange is crucial for the scientific productivity of a
country and this should certainly be used much more often in
orderly to open perspectives for the next generation and to
nourish running projects upon their return to their home
country. What’s valid in politics is also true in European
medicine and science: L’union fait la force!
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